Skip to main content
Clinical Trials/JPRN-UMIN000007005
JPRN-UMIN000007005
Not Yet Recruiting
N/A

The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgery - The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgery

Osaka Medical College0 sites200 target enrollmentJanuary 10, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
colorectal cancer
Sponsor
Osaka Medical College
Enrollment
200
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 10, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • patients who are thout to be inapropreate for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarction
JPRN-UMIN000010477Department of Neurology, Kansai Medical University50
Recruiting
N/A
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)
JPRN-UMIN000021138ihon University school of medicine150
Not Yet Recruiting
Phase 3
Effectiveness and safety of blood thinning agent (Anticoagulation) in patients with dying limb with poor blood supply (Digital Gangrene) and an underlying immune system related disease (Connective Tissue Disease)Health Condition 1: M339- Dermatopolymyositis, unspecifiedHealth Condition 2: M319- Necrotizing vasculopathy, unspecifiedHealth Condition 3: M340- Progressive systemic sclerosisHealth Condition 4: M368- Systemic disorders of connective tissue in other diseases classified elsewhereHealth Condition 5: M359- Systemic involvement of connectivetissue, unspecifiedHealth Condition 6: M321- Systemic lupus erythematosus withorgan or system involvement
CTRI/2024/03/063481Department of Clinical Immunology & Rheumatology
Completed
N/A
A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWAAtrial fibrillation
JPRN-UMIN000011830ASSAF-K steering committee5,000
Completed
N/A
The Efficacy of Pro- and Anticoagulant Therapy in Plasma of Patients with Cirrhosis undergoing Orthotopic Liver TransplantatiobleedingThrombosis100196541000318410014523
NL-OMON42693niversitair Medisch Centrum Groningen60